NCT00455767View on ClinicalTrials.gov

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
FibrosisLung DiseaseRespiratory DisordersRespiratory Distress Syndrome, AdultAcute Respiratory Distress SyndromePulmonary FibrosisInflammation
Interventions
DRUG

EPI-hNE4

I.V. injection of 1mg/kg Depelestat (EPI-hNE4) 3 times daily for 7 days

DRUG

Placebo

Placebo

Trial Locations (14)

33076

Yves Castaing, Bordeaux

34295

Samir Jaber, Montpellier

38043

Jean-François Timsit, Grenoble

49933

Alain Mercat, Angers

69004

Claude Guerin, Lyon

75651

Jean-Jacques Rouby, Paris

75679

Jean-Daniel Chiche, Paris

75908

Jean-Yves Fagon, Paris

76031

Jean-Christophe Richard, Rouen

83100

Jean-Michel Arnal, Toulon

94010

Laurent Brochard, Créteil

00168

Massimo Antonelli, Roma

08025

Jordi Mancebo D., Barcelona

Unknown

Fekri Abroug, Monastir

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY